Joanne Curley - 12 Dec 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Development Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
12 Dec 2022
Net transactions value
-$148,140
Form type
4
Filing time
14 Dec 2022, 15:08:34 UTC
Previous filing
08 Dec 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $75,900 +6,900 +26% $11.00 33,721 12 Dec 2022 Direct
transaction VERA Class A Common Stock Sale $125,924 -6,900 -20% $18.25 26,821 12 Dec 2022 Direct F1, F2
transaction VERA Class A Common Stock Options Exercise $129,063 +11,733 +44% $11.00 38,554 13 Dec 2022 Direct
transaction VERA Class A Common Stock Sale $214,441 -11,733 -30% $18.28 26,821 13 Dec 2022 Direct F1, F3
transaction VERA Class A Common Stock Options Exercise $6,870 +1,078 +4% $6.37 27,899 13 Dec 2022 Direct
transaction VERA Class A Common Stock Sale $19,609 -1,078 -3.9% $18.19 26,821 13 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Options (right to buy) Options Exercise $0 -6,900 -8.2% $0.000000 77,117 12 Dec 2022 Class A Common Stock 6,900 $11.00 Direct F4
transaction VERA Stock Option (right to buy) Options Exercise $0 -11,733 -15% $0.000000 65,384 13 Dec 2022 Class A Common Stock 11,733 $11.00 Direct F4
transaction VERA Stock Options (right to buy) Options Exercise $0 -1,078 -11% $0.000000 8,639 13 Dec 2022 Class A Common Stock 1,078 $6.37 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.41, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.09 to $18.92, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter.
F5 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.